about
Sub-clinical atrophy of the retinal nerve fibre layer in multiple sclerosis.The effect of phacoemulsification cataract surgery on polarimetry and tomography measurements for glaucoma diagnosis.Retinal nerve fibre layer evaluation in ocular hypertensive eyes using optical coherence tomography and scanning laser polarimetry in the diagnosis of early glaucomatous defects.Reliability and validity of Cirrus and Spectralis optical coherence tomography for detecting retinal atrophy in Alzheimer's disease.Effect of optic neuritis on progressive axonal damage in multiple sclerosis patients.Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients.Performance of imaging devices versus optic disc and fiber layer photography in a clinical practice guideline for glaucoma diagnosis.Normal reference ranges of optical coherence tomography parameters in childhood.Predictive value of confocal scanning laser for the onset of visual field loss in glaucoma suspects.Ability and reproducibility of Fourier-domain optical coherence tomography to detect retinal nerve fiber layer atrophy in Parkinson's disease.Three-dimensional geometries representing the retinal nerve fiber layer in multiple sclerosis, optic neuritis, and healthy eyes.Influence of cataract surgery on optical coherence tomography and neurophysiology measurements in patients with retinitis pigmentosa.Influence of cataract surgery on repeatability and measurements of spectral domain optical coherence tomography.Retinal thinning and correlation with functional disability in patients with Parkinson's disease.Predictive value of retrobulbar blood flow velocities in glaucoma suspects.Bilateral choroidal metastases as presentation of dissemination of cutaneous malignant melanoma.Role of color Doppler imaging in early diagnosis and prediction of progression in glaucoma.Managing IBD outside the gut: ocular manifestations.Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma.Relationship between standard automated perimetry and retinal nerve fiber layer parameters obtained with optical coherence tomography.Retinal nerve fibre layer thickness in ARSACS: myelination or hypertrophy?Artificial neural network techniques to improve the ability of optical coherence tomography to detect optic neuritis.Neuro-ophthalmologic evaluation, quality of life, and functional disability in patients with MS.Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration.Neural networks to identify multiple sclerosis with optical coherence tomography.Pathways of neuronal and cognitive development in children born small-for-gestational age or late preterm.Retinal layer segmentation in patients with multiple sclerosis using spectral domain optical coherence tomography.Electrophysiology and optical coherence tomography to evaluate Parkinson disease severity.New findings in the ataxia of Charlevoix-Saguenay.Vitreous pharmacokinetics and bioavailability of memantine after subtenon, intravenous, and intravitreal administration in rabbits.Topographic relationship between frequency-doubling technology threshold values.Is the ataxia of Charlevoix-Saguenay a developmental disease?Application of electrophysiological tests in the study of neurological diseases with visual involvement.[Finding of retinal nerve fiber layer hypertrophy in ataxia of Charlevoix-Saguenay patients].Retinal segmentation as noninvasive technique to demonstrate hyperplasia in ataxia of Charlevoix-Saguenay.RETINA MEASUREMENTS FOR DIAGNOSIS OF PARKINSON DISEASEEffect of Cataract Surgery on Optical Coherence Tomography Measurements and Repeatability in Patients With Non-Insulin–Dependent Diabetes MellitusDiagnostic Ability of a Linear Discriminant Function for Spectral-Domain Optical Coherence Tomography in Patients with Multiple SclerosisDetection of retinal nerve fiber layer degeneration in patients with Alzheimer's disease using optical coherence tomography: searching new biomarkers
P50
Q33458744-DAE6EFED-2E41-4F2D-8BD5-B1FC1A25E487Q33522095-22EE4520-AC88-4849-86F9-080B22EE8AB5Q33615654-8EC03FE5-35D6-4632-B1A2-4DD3B704AC30Q33759154-8A18EC9B-D2F6-42BF-BD3B-68785A27CB8DQ33814175-B4830CEA-9A26-49CE-BBA1-225EA711C47FQ33969869-784F2546-CD76-4C6E-8294-7E309E71EBEEQ34073975-026B927E-A928-42B8-92A8-2679AC4A7357Q34157228-3F5A09C2-E900-4B3D-B835-110A5CABF00AQ34268485-8EE71282-1D32-4D76-AF2B-FB97F9606EC2Q34322914-92B5A23F-1E60-4B1E-8AF0-60753BFFC948Q34351429-8FBE6122-7C22-4DA2-A24D-4F3D33EA2445Q34724754-F14C3235-4F72-444C-A626-529673513B93Q35029316-0A95DA0F-1EB6-4F80-BDD5-E22F4B74C6A5Q35052814-E8348939-83DD-4CBF-B493-61B3DF053DBDQ36077779-6927A68C-002F-40A7-89DA-E669E3BC2E18Q36361008-F4F35093-2F32-48C3-BD24-51216D3DE9C0Q37212317-14D8D3FD-6D20-4E16-8A56-B59BD08E3737Q38136957-7A16C31B-DBD2-455E-9BAB-096215BED01EQ42475565-BC8A103A-02F5-4CC9-BE36-982E319011DDQ42482702-EBE34C4A-05E7-408A-B21B-9894F941776CQ42483243-4159E72C-8E75-4303-BBB2-2D5FA7611962Q42923907-3F9280B9-D26E-4AB2-947E-172EA720FDF8Q43434993-C2765437-62D8-49EB-93D6-86FAB8342E35Q43755865-7B954EC2-2BDC-4368-86EB-578715B2FAA4Q44615841-A64B1145-6705-4D15-B16F-B0B4144A49DCQ45007879-4BE75AB0-7CCE-4C6F-9F4F-FD49D110B419Q45046002-EE8A784A-6657-439D-B2F7-B0493A4D038BQ46405547-A3E8E270-5B0E-4828-A5BE-F709C5C96986Q48096914-FB5F216C-71E9-4791-A16C-F82031BEC417Q48846881-D0DCB491-7165-4CD7-A849-2956FE3D0A0CQ51156217-D95F2B16-ABEE-4967-8241-59E012333EE6Q51493656-7435C10D-1666-464A-8BFA-D5DB238789D9Q51864464-6F8C5438-52B9-45BC-BB44-C324EEA55F92Q53442809-43801DBF-4B49-4645-ACBF-04F20F2791E1Q54545218-29440CA4-F7B3-4D98-97D7-6AE181D24A53Q54785270-EB362F6B-35BB-4FDB-864B-0E25D5465254Q59697298-E7FACFD2-CE72-421A-BD46-B8C947B411DBQ59697301-DAB466E5-6569-4174-A939-493B271BC64CQ59697306-5ADB8779-39C5-43DD-B6E5-7E7F94245DBBQ59697325-96221E26-6232-4C4B-824C-AC4E03F32F48
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Luis Emilio Pablo
@ast
Luis Emilio Pablo
@en
Luis Emilio Pablo
@es
Luis Emilio Pablo
@nl
Luis Emilio Pablo
@sl
type
label
Luis Emilio Pablo
@ast
Luis Emilio Pablo
@en
Luis Emilio Pablo
@es
Luis Emilio Pablo
@nl
Luis Emilio Pablo
@sl
prefLabel
Luis Emilio Pablo
@ast
Luis Emilio Pablo
@en
Luis Emilio Pablo
@es
Luis Emilio Pablo
@nl
Luis Emilio Pablo
@sl
P106
P21
P31
P496
0000-0003-2389-8282